Ellagic acid and polyphenolics present in walnut kernels inhibit in vitro human peripheral blood mononuclear cell proliferation and alter cytokine production

Annals of the New York Academy of Sciences

Volumn 1190, Issue , 2010, Pages 86-96

  Anderson, Koren C ^a   Teuber, Suzanne S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ellagic acid; Juglans regia; Nut allergy; Polyphenolics; Walnut

Indexed keywords

CYTOKINE; ELLAGIC ACID; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; POLYPHENOL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; CELL PROLIFERATION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOOD ALLERGY; HUMAN; IN VITRO STUDY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; WALNUT;

JUGLANS; JUGLANS REGIA;

EID: 77950203508     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05259.x     Document Type: Conference Paper

References (69)

1. Fraser, G.E. et al. 1992. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch. Intern. Med. 152: 1416-1424.
2. Hu, F.B. et al. 1998. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. Brit. Med. J. 317: 1341-1345.
3. Sabate, J. 1999. Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am. J. Clin. Nutr. 70: 500S-503S.
4. Abbey, M. et al. 1994. Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. Am. J. Clin. Nutr. 59: 995-999.
5. Zambon, D. et al. 2000. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial. Ann. Intern. Med. 132: 538-546.
6. Sabate, J. et al. 1993. Effects of walnuts on serum lipid levels and blood pressure in normal men.N.Engl. J.Med. 328: 603-607.
7. Chisholm,A. et al. 1998.Adiet rich inwalnuts favourably influences plasma fatty acid profile in moderately hyperlipidaemic subjects. Eur. J. Clin. Nutr. 52: 12-16.
8. Tapsell, L.C. et al. 2004. Including walnuts in a lowfat/ modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 27: 2777-2783.
9. Ros, E. 2009. Nuts and novel biomarkers of cardiovascular disease. Am. J. Clin. Nutr. 89: 16495-16565.
10. Morgan,W.A.,& B.J.Clayshulte. 2000. Pecans lower lowdensity lipoprotein cholesterol in people with normal lipid levels. J. Am. Diet. Assoc. 100: 312-318.
11. Durak, I. et al. 1999. Hazelnut supplementation enhances plasma antioxidant potential and lowers plasma cholesterol levels. Clin. Chim. Acta 284: 113-115.
12. Fraser, G.E. 1999. Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non- Hispanic white California Seventh-day Adventists. Am. J. Clin. Nutr. 70: 2S-538S.
13. Kris-Etherton, P.M. et al. 1999. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am. J. Clin. Nutr. 70: 504S- 511S.
14. Anderson, K.J. et al. 2001.Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J. Nutr. 131: 2837-2842.
15. Renaud, S. & M. de Lorgeril. 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526.
16. Keli, S.O. et al. 1996. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch. Intern. Med. 156: 637-642.
17. Hertog, M.G. et al. 1995. Flavonoid intake and longterm risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155: 381-386.
18. Fink, B.N. et al. 2007. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidmiol. Biomarkers Prev. 16: 2285-2292.
19. Murso, J. et al. 2008. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br. J. Nutr. 100: 890-895.
20. Bravo, L. 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56: 317-333.
21. Stevenson, D.E. & R.D. Hurst. 2007. Polyphenolic polyphenols - just antioxidants ormuch more? Cell Mol. Life Sci. 64: 2900-2916.
22. Biesalski, H.K. 2007. Polyphenols and inflammation: basic interactions. Curr. Opin. Clin. Nutr. Metab. Care 10: 724-728.
23. Bock, S.A., A. Munoz-Furlong, & H.A. Sampson. 2007. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J. Allergy Clin. Immunol. 119: 1016-1018.
24. Teuber, S.S. et al. 2003. Tree nut allergy. Curr. Allergy Asthma Reports 3: 54-61.
25. Sack, M.N., R.M. Smith, & L.H. Opie. 2000. Tumor necrosis factor in myocardial hypertrophy and ischaemia-an anti-apoptotic perspective. Cardiovasc. Res. 45: 688-695.
26. Jurd, L. 1956. The polyphenolic constituents of the pellicle of the walnut (Juglans regia). J. Am. Chem. Soc. 78: 3445-3448.
27. Jurd, L. 1958. The isolation of a new ellagitannin fromthe pellicle of the walnut. J. Am. Chem. Soc. 80: 2249-2252.
28. de Boer, J.G. et al. 2004. Chemoprotection against Nnitrosomethylbenzylamine- induced mutation in the rat esophagus. Nutr. Cancer 50: 168-173.
29. Makena, P.S.&K.T.Chung. 2007. Effects of various plant polyphenols on bladder carcinogen benzidine-induced mutagenicity. Food Chem. Toxicol. 45: 1899-1909.
30. Mertens-Talcott, S.U. et al. 2003. Low concentrations of querceting and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis inMOLT-4 human leukemia cells. J. Nutr. 133: 2669-2674.
31. Papoutsi, Z. et al. 2008. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit antiinflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483.Br. J. Nutr. 99: 715-722.
32. Losso, J.N. et al. 2004. In vitro anti-proliferative activities of ellagic acid. J. Nutr. Biochem. 15: 672-678.
33. Fjaeraa, C. & E. Nanberg. 2009. Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells. Biomed. Pharmacother. 63: 254-261.
34. de Vries, J.H. et al. 1998. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am. J. Clin. Nutr. 68: 60-65.
35. Wiseman, H. 1999. The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens. Proc. Nutr. Soc. 58: 139-146.
36. Narayanan, B.A. et al. 1999. p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett. 136: 215-221.
37. Narayanan, B.A., & G.G. Re. 2001. IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Res. 21: 359-364.
38. Singleton, V.L. & J.A. Rossi. 1965. Colorimetry of total phenolics with phosphomalybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 16: 144-158.
39. Dawra, R.K., H.P. Makkar, & B. Singh. 1988. Proteinbinding capacity of microquantities of tannins. Anal. Biochem. 170: 50-53.
40. Teuber, S.S., A.M. Dandekar, et al. 1998. Cloning and sequencing of a gene encoding a 2S albumin seed storage protein precursor from English walnut (Juglans regia) - a major food allergen. J. Allergy Clin. Immunol. 101: 807-814.
41. Teuber, S.S. et al. 1999. Identification and cloning of a complementaryDNA encoding a vicilin-like proprotein, Jug r 2, from English walnut kernel (Juglans regia), a major food allergen. J. Allergy Clin. Immunol. 104: 1311-1320.
42. Wallowitz, M. et al. 2006. Jug r 4, a legumin group food allergen from walnut (Juglans regia Cv. Chandler). J. Agric. Food Chem. 54: 8369-8375.
43. Amellal, M. et al. 1985. Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med. 1: 16-20.
44. Matsuo, N. et al. 1997. Effect of tea polyphenols on histamine release from rat basophilic leukemia (RBL- 2H3) cells: the structure-inhibitory activity relationship. Allergy 52: 58-64.
45. Baum, C.G. et al. 1990. Cellular control of IgE induction by a polyphenol-rich compound. Preferential activation of Th2 cells. J. Immunol. 145: 779-784.
46. Akiyama, H. et al. 2000. Antiallergic effect of apple polyphenols on the allergic model mouse. Biol. Pharm. Bull. 23: 1370-1373.
47. Kotani, M., M. Matsumoto, et al. 2000. Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J. Allergy Clin. Immunol. 106: 159-166.
48. Yu, C.R., R.A. Kirken, et al. 1998. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary humanNKandTcells: a comparative study with IL-4. J. Immunol. 161: 218-227.
49. Essayan,D.M.,G.Krishnaswamy, et al. 1999. Differential regulation of antigen-induced IL-4 and IL-13 generation from T lymphocytes by IFN-alpha. J. Allergy Clin. Immunol. 103: 451-457.
50. Oettgen,H.C. 2000. Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts. Curr. Opin. Immunol. 12: 618-623.
51. De Amici, M., F. Puggioni, et al. 2001. Variations in serum levels of interleukin (IL)-1beta, IL-2, IL-6, and tumor necrosis factor-alpha during specific immunotherapy. Ann. Allergy Asthma Immunol. 86: 311-313.
52. Devi, M.A. & N.P. Das. 1993. In vitro effects of natural plant polyphenols on the proliferation of normal and abnormal human lymphocytes and their secretions of interleukin-2. Cancer Lett. 69: 191-196.
53. Sanbongi, C., N. Suzuki & T. Sakane. 1997. Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunol. 177: 129-136.
54. Mao, T., J. van deWater, et al. 2000. Cocoa procyanidins and human cytokine transcription and secretion. J.Nutr. 130: 2093S-2099S.
55. Smith-Garvin, J.E., G.A. Koretzky, & M.S. Jordan. 2009. T cell activation. Ann. Rev. Immunol. 27: 591-619.
56. Mookerjee, B.K., T.P. Lee, et al. 1986. The effects of flavonoids on human lymphocyte proliferative responses. Prog. Clin. Biol. Res. 213: 511-520.
57. Pereira, R.L., T. Ibrahim, et al. 1999. Immunosuppressive and anti-inflammatory effects of methanolic extract and the polyacetylene isolated from Bidens pilosa L. Immunopharmacol 43: 31-37.
58. Hirano, T., K. Oka, et al. 1989. Effects of synthetic and naturally occurring flavonoids on mitogen-induced proliferation of human peripheral-blood lymphocytes. Life Sci. 45: 1407-1411.
59. Namgoong, S.Y., K.H. Son, et al. 1994. Effects of naturally occurring flavonoids on mitogen-induced lymphocyte proliferation and mixed lymphocyte culture. Life Sci. 54: 313-320.
60. Kashiwada,Y.,G.Nonaka, et al. 1992.Tannins as selective inhibitors of protein kinase C. Bioorg. Med. Chem. Lett. 2: 239-244.
61. Kashiwada, Y., L. Huang, et al. 1994. New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C. J. Med. Chem. 37: 195-200.
62. Leca, G., L. Boumsell, et al. 1986. The sheep erythrocyte receptor and both alpha and beta chains of the human T-lymphocyte antigen receptor bind the mitogenic lectin (phytohaemagglutinin) from Phaseolus vulgaris. Scand. J. Immunol. 23: 535-544.
63. Kumar, S., & R. Chakrabarti. 2000. [8- (Diethylamino)octyl-3,4,5- trimethoxybenzoate, HCl], the inhibitor of intracellular calcium mobilization, blocked mitogen-induced T cell proliferation by interfering with the sustained phase of protein kinase C activation. J. Cell Biochem. 76: 539-547.
64. Geiselhart, L., D.J. Conti & B.M. Freed. 1996. RO 31- 8220, a novel protein kinase C inhibitor, inhibits early and late T cell activation events. Transplantation 61: 1637-1642.
65. Kuo, Y.C., N.S. Yang, et al. 2000. Regulation of cell proliferation, gene expression, production of cytokines, and cell cycle progression in primary human T lymphocytes by piperlactam S isolated from Piper kadsura.Mol. Pharmacol. 58: 1057-1066.
66. Yea, S. S.,H.M. Kim, et al. 2000. Suppression of IL-2 and IL-4 gene expression by nodularin through the reduced NF-AT binding activity. Toxicol. Lett. 114: 215-224.
67. Modiano, J.F., R. Kolp, et al. 1991. Protein kinase C regulates both production and secretion of interleukin 2. J. Biol. Chem. 266: 10552-10561.
68. Hassan, J., E. Rainsford, & D.J. Reen. 1997. Linkage of protein kinase C-beta activation and intracellular interleukin-2 accumulation in human naive CD4 T cells. Immunology 92: 465-471.
69. Grove,D.S.,& A.M.Mastro. 1991. Differential activation and inhibition of lymphocyte proliferation by modulators of protein kinase C: diacylglycerols, "rationally designed" activators and inhibitors of protein kinase C. Exp. Cell Res. 193: 175-182.